ESR1 and neoplasm: Among these therapies are the selective ER modulator, tamoxifen, which inhibits tumour growth by binding and blocking ER (EBCTCG 1998) and aromatase inhibitors (AIs) that inhibit the enzyme that converts androgens into oestrogen (Gradishar 2004).